(139) found that the treatment of CLL with anti-PD-L1 in combination with IL-10 produces more IFN-γ+, memory CD8+ T-cells, and cytotoxic effector KLRG1+, and fewer exhausted T-cells than anti-PD-L1 alone. This evidence concerns the gene CD274 and B-cell chronic lymphocytic leukemia.